Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Ceftazidime and Avibactam Sodium for Injection
- Product Name
- 注射用头孢他啶阿维巴坦钠
- Approval Number
- 国药准字H20234289
- Approval Date
- Oct 12, 2023
NMPA
Tedizolid Phosphate for Injection
- Product Name
- 注射用磷酸特地唑胺
- Approval Number
- 国药准字H20233801
- Approval Date
- Jun 27, 2023
NMPA
Erlotinib Hydrochloride Tablets
- Product Name
- 盐酸厄洛替尼片
- Approval Number
- 国药准字H20213491
- Approval Date
- Jun 16, 2021
NMPA
Erlotinib Hydrochloride Tablets
- Product Name
- 盐酸厄洛替尼片
- Approval Number
- 国药准字H20213492
- Approval Date
- Jun 16, 2021
NMPA
Clinical Trials
No trials found
News
No news found